You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

XLA

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Common Variable Immunodeficiency and Related Syndromes

Recruiting
  • CVID
  • XLA
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Obesity, Metabolic Disease Trial in Lincoln (Xla1, Placebo)

    Completed
    • Obesity
    • Metabolic Disease
    • Lincoln, Nebraska
      Celerion
    Jul 12, 2021

    COVID-19 Vaccine Responses in PIDD Subjects

    Recruiting
    • X-linked Agammaglobulinemia
    • +6 more
      • Saint Petersburg, Florida
      • +2 more
      Apr 7, 2022

      Assessing the Onset, Progression and Sequelae of COVID-19

      Recruiting
      • COVID-19
      • Observe and record
      • Beijin, China
        Xiyuan Hospital of China Academy of Chinese Medical Sciences
      Mar 8, 2023

      COVID-19 Trial (Huashi Baidu Granule, Monapiravir)

      Not yet recruiting
      • COVID-19
      • (no location specified)
      Dec 5, 2022

      Gastroesophageal Reflux, Functional Dysphonia Trial in Beijing (Tongjiang granule, Tongjiang granule simulant)

      Recruiting
      • Gastroesophageal Reflux
      • Functional Dysphonia
      • Tongjiang granule
      • Tongjiang granule simulant
      • Beijing, Beijing, China
        Xiyuan Hospital of China Academy of Chinese Medical Sciences
      Apr 1, 2022

      Primary Immunodeficiency Disease Trial (Boya IVIG)

      Not yet recruiting
      • Primary Immunodeficiency Disease
      • Boya IVIG
      • (no location specified)
      Nov 21, 2023

      Primary Immunodeficiency Disease Trial (IVIG)

      Not yet recruiting
      • Primary Immunodeficiency Disease
      • IVIG
      • (no location specified)
      Oct 16, 2023

      Stable Coronary Heart Disease Trial in Beijing (Zhenyuan capsule)

      Unknown status
      • Stable Coronary Heart Disease
      • Zhenyuan capsule
      • Beijing, China
        Xiyuan Hospital of China Academy of Chinese Medical Sciences
      Jun 4, 2020

      COVID-19 Trial in Beijing (Traditional Chinese Medicine Prescription)

      Unknown status
      • COVID-19
      • Traditional Chinese Medicine Prescription
      • Beijing, Beijing, China
        Hao Li
      Mar 24, 2020

      Cognitive Dysfunction Trial in Beijing (Gulingji capsules, Ginko Biloba Extract tablet)

      Unknown status
      • Cognitive Dysfunction
      • Gulingji capsules
      • Ginko Biloba Extract tablet
      • Beijing, Beijing, China
        Li Hao
      Aug 23, 2018

      Primary Immune Deficiency Disease Trial in United States (Flebogamma 5% DIF)

      Completed
      Has Results
      • Primary Immune Deficiency Disease
      • Flebogamma 5% DIF
      • St. Petersburg, Florida
      • +6 more
      Dec 7, 2016

      Agammaglobulinemia, BTK Trial in Shanghai

      Unknown status
      • Agammaglobulinemia, BTK
        • Shanghai, Shanghai, China
          Shanghai Children'S Medical Center
        Sep 4, 2014

        Primary Immune Deficiency Trial in United States (IgPro20)

        Completed
        Has Results
        • Primary Immune Deficiency
        • IgPro20
        • Centennial, Colorado
        • +3 more
        Mar 5, 2014

        Common Variable Immunodeficiency, Agammaglobulinemia Trial in Worldwide (Vivaglobin)

        Completed
        Has Results
        • Common Variable Immunodeficiency
        • Agammaglobulinemia
        • Edmonton, Alberta, Canada
        • +5 more
        Jun 12, 2013